HIF1A and neoplasm: EAF2 also reportedly binds to and stabilizes von Hippel-Lindau protein (pVHL), a tumor suppressor involved in mediating HIF1α degradation and an inhibitor of the hypoxia pathway, which suggests it is a potential metabolic regulator [25].